astrazeneca pipeline | Pipeline

Keyword	CPC	PCC	Volume	Score	Length of keyword
astrazeneca pipeline	1.57	0.8	2671	59	20
astrazeneca	1.27	0.5	3416	63	11
pipeline	1.26	0.6	8304	84	8

Keyword	CPC	PCC	Volume	Score
astrazeneca pipeline	0.92	0.2	9757	62
astrazeneca pipeline 2023	0.41	0.9	1535	6
astrazeneca pipeline 2022	1.34	0.4	4787	23
astrazeneca pipeline pdf	0.98	0.8	49	46
astrazeneca pipeline covid	0.65	0.2	4202	70
astrazeneca pipeline drugs	1.44	0.2	8858	80
astrazeneca pipeline 2017	1.58	0.9	6709	49
astrazeneca pipeline oncology	0.03	0.7	5523	12
astrazeneca pipeline 2021	1.85	0.4	1315	61
astrazeneca pipeline respiratory	1.26	0.5	7123	53
astrazeneca pipeline 2022 pdf	1.43	0.1	1893	45
astrazeneca cvrm pipeline	1.5	0.3	7251	32
astrazeneca drug pipeline	0.64	0.2	2590	51
astrazeneca vaccine pipeline	1.97	0.5	7282	8
astrazeneca lung cancer pipeline	1.76	0.6	134	89
astrazeneca canada pipeline	0.28	0.8	8369	19

Search Results related to astrazeneca pipeline on Search Engine

Pipeline - AstraZeneca
astrazeneca.com

https://www.astrazeneca.com/our-therapy-areas/pipeline.html

WEBOur pipeline forms a robust portfolio of investigational therapies in varied stages of clinical development.

DA: 51 PA: 51 MOZ Rank: 17

Oncology – AstraZeneca - Portfolio & Pipeline
astrazeneca.com

https://www.astrazeneca.com/our-therapy-areas/oncology/medicines-portfolio-and-pipeline.html

WEBExplore our Oncology pillars. We have one of the most diverse portfolios & pipelines - encompassing molecules and modalities designed to preferentially kill cancer cells, at every stage.

DA: 51 PA: 84 MOZ Rank: 83

AstraZeneca advances its pipeline and highlights progress in …
astrazeneca.com

https://www.astrazeneca.com/media-centre/press-releases/2023/astrazeneca-advances-its-pipeline-and-highlights-progress-in-immuno-oncology-adcs-cell-therapy-and-epigenetics-at-aacr.html

WEBApr 14, 2023 · AstraZeneca will present new data across its diverse, industry-leading Oncology pipeline and portfolio at the American Association for Cancer Research (AACR) Annual Meeting, 14 to 19 April 2023.

DA: 17 PA: 92 MOZ Rank: 58

AstraZeneca aims to transform the oncology treatment landscape …
astrazeneca.com

https://www.astrazeneca.com/media-centre/press-releases/2022/astrazeneca-aims-to-transform-the-oncology-treatment-landscape-with-diverse-early-pipeline-and-novel-combinations-at-aacr.html

WEBMar 28, 2022 · It is through persistent innovation that AstraZeneca has built one of the most diverse portfolios and pipelines in the industry, with the potential to catalyse changes in the practice of medicine and transform the patient experience. AstraZeneca has the vision to redefine cancer care and, one day, eliminate cancer as a cause of death. …

DA: 91 PA: 8 MOZ Rank: 20

What science can do - AstraZeneca
astrazeneca.com

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2021/pdf/AstraZeneca_Development_Pipeline_2021.pdf

WEBAstraZeneca Development Pipeline as at 10 February 2022. References to Notes and page numbers, and capitalised terms not defined in this supplement can be found in AstraZeneca’s Annual ... Development Pipeline 1 Development Pipeline as at 10 February 2022. Compound Mechanism Area Under Investigation Imfinzi + FOLFOX + …

DA: 90 PA: 90 MOZ Rank: 57

Cardiovascular, Renal and Metabolism (CVRM) | AstraZeneca
astrazeneca.com

https://www.astrazeneca.com/our-therapy-areas/cardiovascular-renal-and-metabolism.html

WEBBy combining pioneering science, digital technologies, big data and AI with the skills and experience of talented people, our pipeline goes beyond traditional small molecules, monoclonal antibodies and peptides, to include nucleotide modalities such as antisense oligonucleotides and small interfering RNA, and novel gene and cell therapies that ...

DA: 55 PA: 35 MOZ Rank: 54

AstraZeneca showcases strength of haematology portfolio and pipeline
astrazeneca.com

https://www.astrazeneca.com/media-centre/press-releases/2022/astrazeneca-showcases-strength-of-haematology-portfolio-and-pipeline-across-multiple-hard-to-treat-conditions-at-ash-2022.html

WEBNov 30, 2022 · AstraZeneca will present 47 abstracts showcasing new data from across its haematology portfolio and clinical pipeline, demonstrating its commitment to redefining care for hard-to-treat blood diseases at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition, 10 to 13 December 2022.

DA: 79 PA: 32 MOZ Rank: 25

AstraZeneca Advances Ambition to Redefine Care for Blood …
businesswire.com

https://www.businesswire.com/news/home/20211105005227/en/AstraZeneca-Advances-Ambition-to-Redefine-Care-for-Blood-Cancer-at-ASH-2021

WEBNov 5, 2021 · Emerging pipeline molecules show therapeutic potential in novel combinations. Preclinical data will be presented showing that capivasertib (AZD5363), an AKT inhibitor being evaluated in a number ...

DA: 56 PA: 39 MOZ Rank: 94

AstraZeneca to Showcase Transformative Data Across Diverse Pipeline …
businesswire.com

https://www.businesswire.com/news/home/20210113005403/en/AstraZeneca-to-Showcase-Transformative-Data-Across-Diverse-Pipeline-at-World-Conference-on-Lung-Cancer

WEBJan 13, 2021 · Eleven AstraZeneca medicines and potential new medicines from the pipeline feature in 39 abstracts showcasing the Company’s leadership across different types and stages of lung cancer, including ...

DA: 19 PA: 82 MOZ Rank: 23

AstraZeneca's '2.0' cancer pipeline built on bispecifics
fiercebiotech.com

https://www.fiercebiotech.com/biotech/astrazeneca-aims-20-cancer-pipeline-shares-bispecific-data-esmo

WEBOct 24, 2023 · AstraZeneca aims to create a “2.0” cancer pipeline and is giving ESMO-goers a peek at data for 3 of its bispecific antibody candidates.

DA: 7 PA: 37 MOZ Rank: 52